A detailed history of Azzad Asset Management Inc /Adv transactions in Pfizer Inc stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 7,848 shares of PFE stock, worth $220,136. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,848
Previous 53,410 85.31%
Holding current value
$220,136
Previous $1.54 Billion 85.84%
% of portfolio
0.03%
Previous 0.19%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$25.89 - $29.73 $1.18 Million - $1.35 Million
-45,562 Reduced 85.31%
7,848 $218 Million
Q4 2023

Apr 01, 2024

BUY
$26.13 - $33.94 $52,782 - $68,558
2,020 Added 3.93%
53,410 $1.54 Billion
Q3 2023

Apr 01, 2024

BUY
$32.09 - $37.51 $57,697 - $67,442
1,798 Added 3.63%
51,390 $1.7 Billion
Q2 2023

Apr 01, 2024

BUY
$36.12 - $41.79 $61,873 - $71,586
1,713 Added 3.58%
49,592 $1.82 Billion
Q1 2023

Apr 01, 2024

BUY
$39.39 - $51.28 $67,199 - $87,483
1,706 Added 3.69%
47,879 $1.95 Billion
Q4 2022

Apr 01, 2024

SELL
$41.75 - $54.5 $804,105 - $1.05 Million
-19,260 Reduced 29.43%
46,173 $2.37 Billion
Q3 2022

Apr 01, 2024

BUY
$43.76 - $53.42 $53,299 - $65,065
1,218 Added 1.9%
65,433 $2.64 Billion
Q2 2022

Apr 01, 2024

BUY
$46.53 - $55.17 $990,995 - $1.18 Million
21,298 Added 49.63%
64,215 $2.98 Billion
Q1 2022

Apr 01, 2024

BUY
$45.75 - $56.69 $373,365 - $462,647
8,161 Added 23.48%
42,917 $2.22 Billion
Q4 2021

Apr 01, 2024

BUY
$41.32 - $61.25 $44,790 - $66,395
1,084 Added 3.22%
34,756 $2.05 Billion
Q3 2021

Apr 01, 2024

BUY
$39.25 - $50.42 $52,438 - $67,361
1,336 Added 4.13%
33,672 $1.45 Billion
Q2 2021

Apr 01, 2024

BUY
$35.91 - $40.68 $25,603 - $29,004
713 Added 2.25%
32,336 $1.27 Billion
Q1 2021

Apr 01, 2024

BUY
$33.49 - $37.77 $324,015 - $365,424
9,675 Added 44.08%
31,623 $1.15 Billion
Q4 2020

Apr 01, 2024

BUY
$33.47 - $42.56 $30,691 - $39,027
917 Added 4.36%
21,948 $808 Million
Q3 2020

Apr 01, 2024

BUY
$31.75 - $37.25 $38,131 - $44,737
1,201 Added 6.06%
21,031 $772 Million
Q2 2020

Apr 01, 2024

BUY
$30.12 - $36.54 $597,279 - $724,588
19,830 New
19,830 $648 Million
Q1 2020

Apr 01, 2024

SELL
$27.03 - $38.62 $566,900 - $809,977
-20,973 Closed
0 $0
Q4 2019

Apr 01, 2024

BUY
$32.92 - $37.36 $197 - $224
6 Added 0.03%
20,973 $693 Million
Q3 2019

Apr 01, 2024

BUY
$32.49 - $42.13 $681,217 - $883,339
20,967 New
20,967 $689 Million
Q1 2015

Apr 03, 2024

SELL
N/A
-19,694 Closed
0 $0
Q4 2014

Apr 03, 2024

SELL
N/A
-384 Reduced 1.91%
19,694 $613 Million
Q3 2014

Apr 03, 2024

BUY
N/A
6,813 Added 51.36%
20,078 $594 Million
Q2 2014

Apr 03, 2024

BUY
N/A
237 Added 1.82%
13,265 $394 Million
Q1 2014

Apr 03, 2024

BUY
N/A
685 Added 5.55%
13,028 $418 Million
Q4 2013

Apr 03, 2024

SELL
N/A
-315 Reduced 2.49%
12,343 $378 Million
Q2 2013

Apr 03, 2024

BUY
N/A
1,233 Added 10.79%
12,658 $364 Million
Q1 2013

Apr 03, 2024

SELL
N/A
-41,985 Reduced 78.61%
11,425 $330 Million
Q4 2012

Apr 08, 2024

SELL
N/A
-4,824 Reduced 25.32%
14,225 $357 Million
Q3 2012

Apr 08, 2024

BUY
N/A
19,049 New
19,049 $473 Million
Q2 2011

Apr 08, 2024

SELL
N/A
-27,150 Closed
0 $0
Q1 2011

Apr 08, 2024

SELL
N/A
-17,693 Reduced 39.46%
27,150 $551 Million
Q4 2010

Apr 08, 2024

SELL
N/A
-8,567
44,843 $785 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.